Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
Recruiting · NCT05602376 · Interventional (participants receive a specific treatment) · Lead sponsor: Desmond Tutu HIV Foundation
View the official record on ClinicalTrials.gov →Interventions studied
U=U adherence messaging scriptsU=U testing messaging scripts
What this trial is about
This study will evaluate the impact of U=U messaging and counseling on gaps in the HIV care cascade for men, including testing uptake and ART initiation (Aim 1), achieving viral suppression and retention in care (Aim 2) in two provinces in South Africa. The U=U message communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (\<200 copies/mL) cannot sexually transmit HIV. Additionally, the investigators will conduct a multi-method evaluation to inform future implementation of U=U messaging interventions (Aim 3).
Who can take part
Age range
15 Years and older
Sex
Male
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- AIM 1:
- male
- aged ≥15 years
- present a study issued invitation card to site receptionist
- ability to provide informed consent.
- AIM 2:
- cis-gender men
- aged ≥15 years
- newly initiating ART (i.e., treatment naïve) or re-initiating ART after 6 months of being lost-to-care
- live in Buffalo City or Cape Town Metro Health Districts
- provide written informed consent
Where it is running
2 locations listed.
- Buffalo City Metro - East London, Eastern Cape, South Africa
- Cape Town Metro - Cape Town, Western Cape, South Africa